Company: GANX
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001558370-25-004958
Chunk: 10

Company: Gain Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 10
---
3        | ​ | Approval of an Amendment to our Certificate to increase our authorized shares of common stock from 50,000,000 to 100,000,000                        | ​ | “FOR” votes from a majority of the votes cast at the Annual Meeting.                                                                                                                                                                                                                                                        | ​ | Not applicable | ​ | Not applicable (1) |
| ​        | ​ | ​                                                                                                                                                   | ​ | ​                                                                                                                                                                                                                                                                                                                           | ​ | ​              | ​ | ​                  |
| 4        | ​ | Adjournment of the Annual Meeting                                                                                                                   | ​ | “FOR” votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote thereon.                                                                                                                                                                                                | ​ | Against        | ​ | Not applicable (1) |

| (1) | This proposal may be considered to be a “routine” matter under NYSE rules. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other agent has discretionary authority under NYSE rules to vote your shares on this proposal. |

What is the quorum requirement? A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if the holders of a majority of our capital stock issued and outstanding and entitled to vote is present at the Annual Meeting in person or represented by proxy. On the Record Date, there were [●] shares of common stock outstanding and entitled to vote. Thus, the holders of at least [●] shares must be present in person or represented by proxy at the Annual Meeting to have a quorum. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the meeting. Abstentions and broker non-votes will be

counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting or represented by proxy may adjourn the meeting to another date.

**How can I find out the results of the voting at the Annual Meeting?**

Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form 8